Calderon Chacon, JaninneGaray Borcosque, Andres M.Lijeron Viana de Araujo, Luccas2026-03-222026-03-222025https://andeanlibrary.org/handle/123456789/41931Background: Long-acting antiretroviral therapies (ARV-LA) have emerged as an alternative to daily oral regimens for the management of HIV. This systematic review evaluates the efficacy, safety, and patient satisfaction of ARV-LA, particularly focusing on cabotegravir (CAB-LA) and rilpivirine (RPV-LA), in comparison to standard oral antiretroviral therapies (ART).enHIVLong-Acting Antiretroviral TherapyCabotegravirRilpivirineViral SuppressionSafetyArticle